A researcher leading Thailand's push to manufacture a coronavirus vaccine says its aim is to make it cost-effective and accessible to Southeast Asia, and play a part in preventing a supply shortage globally. Thailand's government announced last week its plans to have a vaccine ready for deployment next year after researchers at Bangkok's Chulalongkorn University successfully conducted trials on mice. Kiat's group has partnered with scientists and biotech companies in North America and wants to mass produce the vaccine in Thailand, at a price more affordable there and in nearby markets like Indonesia, Malaysia, Laos, Vietnam and Myanmar.